Zanotti I - Search Results

1

The Gut Microbial Metabolite Trimethylamine-N-Oxide Is Present in Human Cerebrospinal Fluid.

Del Rio D, Zimetti F, Caffarra P, Tassotti M, Bernini F, Brighenti F, Zini A, Zanotti I. Del Rio D, et al. Among authors: zanotti i. Nutrients. 2017 Sep 22;9(10):1053. doi: 10.3390/nu9101053. Nutrients. 2017. PMID: 28937600 Free PMC article.

2

Pitavastatin increases ABCA1-mediated lipid efflux from Fu5AH rat hepatoma cells.

Zanotti I, Favari E, Sposito AC, Rothblat GH, Bernini F. Zanotti I, et al. Biochem Biophys Res Commun. 2004 Aug 27;321(3):670-4. doi: 10.1016/j.bbrc.2004.07.020. Biochem Biophys Res Commun. 2004. PMID: 15358158

3

Probucol inhibits ABCA1-mediated cellular lipid efflux.

Favari E, Zanotti I, Zimetti F, Ronda N, Bernini F, Rothblat GH. Favari E, et al. Among authors: zanotti i. Arterioscler Thromb Vasc Biol. 2004 Dec;24(12):2345-50. doi: 10.1161/01.ATV.0000148706.15947.8a. Epub 2004 Oct 28. Arterioscler Thromb Vasc Biol. 2004. PMID: 15514211

4

Impaired ATP-binding cassette transporter A1-mediated sterol efflux from oxidized LDL-loaded macrophages.

Favari E, Zimetti F, Bortnick AE, Adorni MP, Zanotti I, Canavesi M, Bernini F. Favari E, et al. Among authors: zanotti i. FEBS Lett. 2005 Dec 5;579(29):6537-42. doi: 10.1016/j.febslet.2005.10.042. Epub 2005 Nov 2. FEBS Lett. 2005. PMID: 16289478 Free article.

5

Pitavastatin effect on ATP binding cassette A1-mediated lipid efflux from macrophages: evidence for liver X receptor (LXR)-dependent and LXR-independent mechanisms of activation by cAMP.

Zanotti I, Potì F, Favari E, Steffensen KR, Gustafsson JA, Bernini F. Zanotti I, et al. J Pharmacol Exp Ther. 2006 Apr;317(1):395-401. doi: 10.1124/jpet.105.093930. Epub 2006 Jan 13. J Pharmacol Exp Ther. 2006. PMID: 16415093

6

A unique protease-sensitive high density lipoprotein particle containing the apolipoprotein A-I(Milano) dimer effectively promotes ATP-binding Cassette A1-mediated cell cholesterol efflux.

Favari E, Gomaraschi M, Zanotti I, Bernini F, Lee-Rueckert M, Kovanen PT, Sirtori CR, Franceschini G, Calabresi L. Favari E, et al. Among authors: zanotti i. J Biol Chem. 2007 Feb 23;282(8):5125-32. doi: 10.1074/jbc.M609336200. Epub 2006 Dec 12. J Biol Chem. 2007. PMID: 17164237 Free article.

7

The LXR agonist T0901317 promotes the reverse cholesterol transport from macrophages by increasing plasma efflux potential.

Zanotti I, Potì F, Pedrelli M, Favari E, Moleri E, Franceschini G, Calabresi L, Bernini F. Zanotti I, et al. J Lipid Res. 2008 May;49(5):954-60. doi: 10.1194/jlr.M700254-JLR200. Epub 2008 Feb 5. J Lipid Res. 2008. PMID: 18252848 Free article.

8

Macrophage, but not systemic, apolipoprotein E is necessary for macrophage reverse cholesterol transport in vivo.

Zanotti I, Pedrelli M, Potì F, Stomeo G, Gomaraschi M, Calabresi L, Bernini F. Zanotti I, et al. Arterioscler Thromb Vasc Biol. 2011 Jan;31(1):74-80. doi: 10.1161/ATVBAHA.110.213892. Epub 2010 Oct 21. Arterioscler Thromb Vasc Biol. 2011. PMID: 20966401

9

The thienotriazolodiazepine Ro 11-1464 increases plasma apoA-I and promotes reverse cholesterol transport in human apoA-I transgenic mice.

Zanotti I, Maugeais C, Pedrelli M, Gomaraschi M, Salgam P, Calabresi L, Bernini F, Kempen H. Zanotti I, et al. Br J Pharmacol. 2011 Nov;164(6):1642-51. doi: 10.1111/j.1476-5381.2011.01376.x. Br J Pharmacol. 2011. PMID: 21449977 Free PMC article.

10

Cellular cholesterol efflux pathways: impact on intracellular lipid trafficking and methodological considerations.

Zanotti I, Favari E, Bernini F. Zanotti I, et al. Curr Pharm Biotechnol. 2012 Feb;13(2):292-302. doi: 10.2174/138920112799095383. Curr Pharm Biotechnol. 2012. PMID: 21470124 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

58 results

Search Page